Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The controversial diabetes drug Avandia should stay on the market for now, with relaxed restrictions on its use, Food and Drug Administration advisers said on Thursday.
The FDA has been reconsidering its approval of Avandia, which was the world?s No. 1 diabetes drug until research showed it could raise the risk of heart attacks and other heart dangers. Since then, its use has been heavily restricted and prescriptions have plummeted, and the FDA wanted to know if it was worth even keeping the drug on the market.
The agency?s expert panel of advisers said the data is clearly confusing and they were deeply divided at the end of two days of hearings on the issue. Most voted to modify the restrictions on Avandia?s use, but not to lift them completely. The FDA usually follows the advice of its panels.
http://vitals.nbcnews.com/_news/201...g-avandia-off-the-market-fda-panel-urges?lite
The FDA has been reconsidering its approval of Avandia, which was the world?s No. 1 diabetes drug until research showed it could raise the risk of heart attacks and other heart dangers. Since then, its use has been heavily restricted and prescriptions have plummeted, and the FDA wanted to know if it was worth even keeping the drug on the market.
The agency?s expert panel of advisers said the data is clearly confusing and they were deeply divided at the end of two days of hearings on the issue. Most voted to modify the restrictions on Avandia?s use, but not to lift them completely. The FDA usually follows the advice of its panels.
http://vitals.nbcnews.com/_news/201...g-avandia-off-the-market-fda-panel-urges?lite